bindarit has been researched along with Allergic Encephalomyelitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cone, R; Ge, S; Guglielmotti, A; Keating, C; Pachter, JS; Paul, D; Shrestha, B | 1 |
1 other study(ies) available for bindarit and Allergic Encephalomyelitis
| Article | Year |
|---|---|
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis.
Topics: Amino Acid Sequence; Animals; Cells, Cultured; Chemokine CCL2; Drug Delivery Systems; Encephalomyelitis, Autoimmune, Experimental; Female; Indazoles; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Propionates; Spinal Cord | 2012 |